What is Jazz Pharmaceuticals's revenue?

Jazz Pharmaceuticals (JAZZ) generated $4.4B in revenue over the trailing twelve months, up 9.2% year over year.

Is Jazz Pharmaceuticals profitable?

Jazz Pharmaceuticals is not currently profitable: it reported a net loss of $266.5M over the trailing twelve months, a -8.9% net margin.

What is Jazz Pharmaceuticals's earnings per share?

Jazz Pharmaceuticals's diluted EPS over the trailing twelve months is $-4.75.

Where does Jazz Pharmaceuticals's income statement data come from?

Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Jazz Pharmaceuticals JAZZ Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$1.07B-10.8%	$1.2B+6.4%	$1.13B+7.7%	$1.05B+16.5%	$897.8M-17.5%
Research and development	$196M—	——	$198.2M+4.3%	$189.97M+5.1%	$180.7M—
Selling, general and administrative	$352.7M-13.2%	$406.21M-23.4%	$530.65M+48.1%	$358.4M-30.3%	$514M+39.2%
Total costs & expenses	$732.3M-22.4%	$943.39M-11.7%	$1.07B-38.3%	$1.73B+81.6%	$953.7M+6.3%
Operating income	$336.6M—	——	$57.51M+108%	-$686.39M-1,128%	-$55.9M-129%
Operating margin	31.5%—	——	5.1%+70.7pp	-65.6%-59.4pp	-6.2%-23.8pp
Interest expense	-$39.9M-110%	$398.2M+920%	-$48.58M-2.6%	-$47.36M+11.8%	-$53.7M-111%
Other income (expense), net	-$3.9M—	——	-$1.02M+92.5%	-$13.54M-308%	$6.5M+309%
Income before income taxes	$299.2M—	——	$9.04M+101%	-$735.55M-570%	-$109.8M-182%
Income tax expense	$6.1M—	$0+100%	-$242.42M-1,312%	-$17.17M+3.5%	-$17.8M+69.3%
Net income	$293.1M—	——	$251.41M+135%	-$718.47M-677%	-$92.5M-148%
Net margin	27.4%—	——	22.3%+91.0pp	-68.7%-58.4pp	-10.3%-27.9pp
Diluted earnings per share	$4.43—	——	$4.08+135%	-$11.74-672%	-$1.52-150%
EBITDA	$518M—	——	$67.91M+110%	-$675.99M-1,386%	-$45.5M-123%
EBITDA margin	48.5%—	——	6%+70.7pp	-64.6%-59.6pp	-5.1%-23.4pp
EBIT	$336.6M—	——	$57.51M+108%	-$686.39M-1,128%	-$55.9M-129%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Jazz Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's revenue?: Jazz Pharmaceuticals (JAZZ) generated $4.4B in revenue over the trailing twelve months, up 9.2% year over year.
Is Jazz Pharmaceuticals profitable?: Jazz Pharmaceuticals is not currently profitable: it reported a net loss of $266.5M over the trailing twelve months, a -8.9% net margin.
What is Jazz Pharmaceuticals's earnings per share?: Jazz Pharmaceuticals's diluted EPS over the trailing twelve months is $-4.75.
Where does Jazz Pharmaceuticals's income statement data come from?: Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.